SILICON LABORATORIES INC
For the period ended Mar 30, 2024. Filed Apr 24, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 30, 2024 · Filed Apr 24, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 5. Other Information
Rule 10b5-1 Trading Arrangements
The following table describes contracts, instructions, or written plans for the purchase or sale of our securities intended to satisfy the affirmative defense conditions of Rule 10b5-1(c), entered into during the quarter ended March 30, 2024. There were no non-Rule 10b5-1 trading arrangements entered into orterminated during the quarter ended March 30, 2024.
| Name and Title of Director or Officer | Date of Adoption of Arrangement | Duration of the Arrangement | Aggregate Number of Securities to be Purchased or Sold Pursuant to the Arrangement |
|---|---|---|---|
| R. Matthew JohnsonPresident and Chief Executive Officer | February 29, 2024 (1) | Expires February 14, 2025 | 8,443 |
| Nina Richardson Director | February 12, 2024 | Expires February 18, 2025 | 600 |
(1) The plan was originally adopted by Mr. Johnson on February 15, 2024 and provided for the sale of up to 15,804 shares of our common stock upon vesting of outstanding equity awards. After consideration of the Company’s stock ownership guidelines, the plan wasamended on February 29, 2024 to reduce the number of shares that may be sold to 8,443.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.